Skip to content
10-Q

Quarterly Report

BIOMET INC

0001402366-14-000009

← back to feed
Filed
Apr 7, 2014 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2014 · Mar 31, 2014 552.4M sh
Stock Repurchased Q3 2014 · Feb 28, 2014 $0
Stock Repurchased Q3 2014 · Feb 28, 2013 $100K
Long Term Debt Q3 2014 · Feb 28, 2014 $5.8B
Long Term Debt Q3 2014 · May 31, 2013 $5.93B
Stockholders Equity Q3 2014 · Feb 28, 2014 $2B
Stockholders Equity Q3 2014 · May 31, 2013 $1.97B
Current Liabilities Q3 2014 · Feb 28, 2014 $644.4M
Current Liabilities Q3 2014 · May 31, 2013 $564.1M
Total Liabilities Q3 2014 · Feb 28, 2014 $7.7B
Total Liabilities Q3 2014 · May 31, 2013 $7.83B
Current Assets Q3 2014 · Feb 28, 2014 $1.77B
Current Assets Q3 2014 · May 31, 2013 $1.77B
Total Assets Q3 2014 · Feb 28, 2014 $9.7B
Total Assets Q3 2014 · May 31, 2013 $9.79B
Capex Q3 2014 · Feb 28, 2013 $149.7M
Operating Cash Flow Q3 2014 · Feb 28, 2013 $273.8M
Cash And Equivalents Q3 2014 · Feb 28, 2013 $217.4M
Cash And Equivalents Q3 2014 · May 31, 2012 $492.4M
Sga Expense restated Q3 2014 · Feb 28, 2013 $327.2M
Sga Expense restated Q3 2014 · Feb 28, 2013 $976M
Rd Expense Q3 2014 · Feb 28, 2013 $35M
Rd Expense Q3 2014 · Feb 28, 2013 $107.2M
Net Income Q3 2014 · Feb 28, 2013 −$304.5M
Net Income Q3 2014 · Feb 28, 2013 −$402.2M
Operating Income Q3 2014 · Feb 28, 2013 −$237.4M
Operating Income Q3 2014 · Feb 28, 2013 −$25.2M
Gross Profit restated Q3 2014 · Feb 28, 2013 $533M
Gross Profit restated Q3 2014 · Feb 28, 2013 $1.62B
Cost Of Revenue restated Q3 2014 · Feb 28, 2013 $238.5M
Cost Of Revenue restated Q3 2014 · Feb 28, 2013 $646.7M
Revenue Q3 2014 · Feb 28, 2013 $771.5M
Revenue Q3 2014 · Feb 28, 2013 $2.27B